论文部分内容阅读
绝经后妇女常伴发骨质疏松症，文中评价了周期性使用重组人生长激素（rh－GH）和降钙素（calcitoni）治疗绝经后骨质疏松症的疗效。84例绝经后骨质疏松症妇女进入研究，72例（86％）完成了24个月的研究。最终有62例病人于36个月时重新进行了骨矿物质密度（BMD）测定。72例完成2
Postmenopausal women are often associated with osteoporosis. The efficacy of cyclical use of recombinant human growth hormone (rh-GH) and calcitoni in the treatment of postmenopausal osteoporosis was evaluated. Eighty-four women with postmenopausal osteoporosis entered the study, and 72 (86%) completed the 24-month study. Finally, 62 patients returned to their bone mineral density (BMD) measurements at 36 months. 72 cases completed 2